Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 17077323)

1.

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.

Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, Coltrini D, Peri F, Pessi A, Orsatti L, Talamo F, Castronovo V, Waltregny D, Cotelli F, Ribatti D, Presta M.

Blood. 2007 Mar 1;109(5):1834-40. Epub 2006 Oct 31.

2.

Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm.

Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M.

Blood. 2008 Aug 15;112(4):1154-7. doi: 10.1182/blood-2007-09-111450. Epub 2008 May 27.

3.

Drm/Gremlin, a BMP antagonist, defines the interbud region during feather development.

Bardot B, Lecoin L, Fliniaux I, Huillard E, Marx M, Viallet JP.

Int J Dev Biol. 2004;48(2-3):149-56.

4.

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.

Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, Ballmer-Hofer K, Zammataro L, Presta M.

Blood. 2010 Nov 4;116(18):3677-80. doi: 10.1182/blood-2010-06-291930. Epub 2010 Jul 21.

5.

The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities.

Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM.

Mol Cell. 1998 Apr;1(5):673-83.

6.

Cutting edge: bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis.

Chen B, Blair DG, Plisov S, Vasiliev G, Perantoni AO, Chen Q, Athanasiou M, Wu JY, Oppenheim JJ, Yang D.

J Immunol. 2004 Nov 15;173(10):5914-7.

7.

BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.

Heinke J, Wehofsits L, Zhou Q, Zoeller C, Baar KM, Helbing T, Laib A, Augustin H, Bode C, Patterson C, Moser M.

Circ Res. 2008 Oct 10;103(8):804-12. doi: 10.1161/CIRCRESAHA.108.178434. Epub 2008 Sep 11.

8.

Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.

Wordinger RJ, Fleenor DL, Hellberg PE, Pang IH, Tovar TO, Zode GS, Fuller JA, Clark AF.

Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1191-200.

PMID:
17325163
9.
10.

Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.

Chiodelli P, Mitola S, Ravelli C, Oreste P, Rusnati M, Presta M.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e116-27. doi: 10.1161/ATVBAHA.111.235184. Epub 2011 Sep 15.

11.

Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.

Corsini M, Moroni E, Ravelli C, Andrés G, Grillo E, Ali IH, Brazil DP, Presta M, Mitola S.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):136-45. doi: 10.1161/ATVBAHA.113.302517. Epub 2013 Nov 14.

12.

Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin.

Pangas SA, Jorgez CJ, Matzuk MM.

J Biol Chem. 2004 Jul 30;279(31):32281-6. Epub 2004 May 6.

13.

Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension.

Costello CM, Howell K, Cahill E, McBryan J, Konigshoff M, Eickelberg O, Gaine S, Martin F, McLoughlin P.

Am J Physiol Lung Cell Mol Physiol. 2008 Aug;295(2):L272-84. doi: 10.1152/ajplung.00358.2007. Epub 2008 May 9.

14.

The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung.

Lu MM, Yang H, Zhang L, Shu W, Blair DG, Morrisey EE.

Dev Dyn. 2001 Dec;222(4):667-80.

15.

Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis.

Shi W, Zhao J, Anderson KD, Warburton D.

Am J Physiol Lung Cell Mol Physiol. 2001 May;280(5):L1030-9.

16.

Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signalling during kidney branching morphogenesis.

Michos O, Gonçalves A, Lopez-Rios J, Tiecke E, Naillat F, Beier K, Galli A, Vainio S, Zeller R.

Development. 2007 Jul;134(13):2397-405. Epub 2007 May 23.

17.

The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.

Lee H, O'Meara SJ, O'Brien C, Kane R.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4291-9.

PMID:
17724219
18.

HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.

Mehta VB, Zhou Y, Radulescu A, Besner GE.

Growth Factors. 2008 Dec;26(6):301-15. doi: 10.1080/08977190802393596.

PMID:
18925469
19.

Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation.

Chen B, Athanasiou M, Gu Q, Blair DG.

Biochem Biophys Res Commun. 2002 Aug 2;295(5):1135-41.

PMID:
12135612
20.

Gremlin promotes vascular smooth muscle cell proliferation and migration.

Maciel TT, Melo RS, Schor N, Campos AH.

J Mol Cell Cardiol. 2008 Feb;44(2):370-9. Epub 2007 Nov 12.

PMID:
18086474
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk